Drug: Tapentadol PR: chronic pain clinical trials
Registry records that list "Drug: Tapentadol PR" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
3
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
3 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics NCT00983385 | Completed | Phase 3 | Austria, Croatia, France, Germany and 5 more | Grünenthal GmbH | 2009-09-30 |
| Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics NCT00983385 | Completed | Phase 3 | Austria, Croatia, France, Germany and 5 more | Grünenthal GmbH | 2009-09-30 |
| Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability. NCT00982280 | Terminated | Phase 3 | Australia, Denmark, Germany, Poland and 2 more | Grünenthal GmbH | 2009-09 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.